Leslie Hayes
Neuromuscular Medicine · Boston, MANPI 1629422589
Payments from drug & device makers
Across 27 payments — averaging $16,947 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$308K
- Vertex$149K
- PTC Therapeutics, Inc.$751
- Biogen$302
- Novartis Gene Therapies, Inc. (fka Avexis, Inc.)$191
- Genentech, Inc.$129
- plus $62 from 1 others
Across 2 payments — averaging $1983.88 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$4K
What the payments were for
- Consulting fees$8,62082%
- Travel & lodging$9829%
- Food & beverage$9069%
- Education$310%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 13 | $307,519 |
| Vertex | 3 | $148,622 |
| PTC Therapeutics, Inc. | 4 | $751 |
| Biogen | 3 | $302 |
| Novartis Gene Therapies, Inc. (fka Avexis, Inc.) | 2 | $191 |
| Genentech, Inc. | 1 | $129 |
| NS Pharma, Inc. | 1 | $62 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few neuromuscular medicine providers in Massachusettsto place this figure against a meaningful peer group, so we don't.
Other neuromuscular medicine in Boston
- Armin MaghsoudlouBoston$856
- Steve HanBoston$225
- Meabh O'HareBoston$159
- Jayshiri SrinsvanBurlington$20K
- Sunjay SethiMilford$1K
- Pooja RaibagkarBurlington$441
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.